Most drug treatments for AD subjects are cholinesterase inhibitors while diabetes treatments mostly involve the use of insulin secretagogues, such as sulfonylurea derivatives, or injectable insulin for blood glucose control. This evidence concerns the gene BCHE and diabetes mellitus.